These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 18767161)

  • 1. Structure-based design of a T-cell receptor leads to nearly 100-fold improvement in binding affinity for pepMHC.
    Haidar JN; Pierce B; Yu Y; Tong W; Li M; Weng Z
    Proteins; 2009 Mar; 74(4):948-60. PubMed ID: 18767161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystal structures of high affinity human T-cell receptors bound to peptide major histocompatibility complex reveal native diagonal binding geometry.
    Sami M; Rizkallah PJ; Dunn S; Molloy P; Moysey R; Vuidepot A; Baston E; Todorov P; Li Y; Gao F; Boulter JM; Jakobsen BK
    Protein Eng Des Sel; 2007 Aug; 20(8):397-403. PubMed ID: 17644531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of TCR-binding properties and antigen presentation format on T cell responsiveness.
    Chervin AS; Stone JD; Holler PD; Bai A; Chen J; Eisen HN; Kranz DM
    J Immunol; 2009 Jul; 183(2):1166-78. PubMed ID: 19553539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engineering the binding properties of the T cell receptor:peptide:MHC ternary complex that governs T cell activity.
    Bowerman NA; Crofts TS; Chlewicki L; Do P; Baker BM; Christopher Garcia K; Kranz DM
    Mol Immunol; 2009 Sep; 46(15):3000-8. PubMed ID: 19595460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T Cell Receptor Engineering and Analysis Using the Yeast Display Platform.
    Smith SN; Harris DT; Kranz DM
    Methods Mol Biol; 2015; 1319():95-141. PubMed ID: 26060072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A flexible docking approach for prediction of T cell receptor-peptide-MHC complexes.
    Pierce BG; Weng Z
    Protein Sci; 2013 Jan; 22(1):35-46. PubMed ID: 23109003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MPID-T: database for sequence-structure-function information on T-cell receptor/peptide/MHC interactions.
    Tong JC; Kong L; Tan TW; Ranganathan S
    Appl Bioinformatics; 2006; 5(2):111-4. PubMed ID: 16722775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human T cells expressing affinity-matured TCR display accelerated responses but fail to recognize low density of MHC-peptide antigen.
    Thomas S; Xue SA; Bangham CR; Jakobsen BK; Morris EC; Stauss HJ
    Blood; 2011 Jul; 118(2):319-29. PubMed ID: 21606483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Directed evolution of human T cell receptor CDR2 residues by phage display dramatically enhances affinity for cognate peptide-MHC without increasing apparent cross-reactivity.
    Dunn SM; Rizkallah PJ; Baston E; Mahon T; Cameron B; Moysey R; Gao F; Sami M; Boulter J; Li Y; Jakobsen BK
    Protein Sci; 2006 Apr; 15(4):710-21. PubMed ID: 16600963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two-step binding mechanism for T-cell receptor recognition of peptide MHC.
    Wu LC; Tuot DS; Lyons DS; Garcia KC; Davis MM
    Nature; 2002 Aug; 418(6897):552-6. PubMed ID: 12152083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T-cell receptor binding affinities and kinetics: impact on T-cell activity and specificity.
    Stone JD; Chervin AS; Kranz DM
    Immunology; 2009 Feb; 126(2):165-76. PubMed ID: 19125887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How peptide/MHC presence affects the dynamics of the LC13 T-cell receptor.
    Dominguez JL; Knapp B
    Sci Rep; 2019 Feb; 9(1):2638. PubMed ID: 30804417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The CDR3 regions of an immunodominant T cell receptor dictate the 'energetic landscape' of peptide-MHC recognition.
    Borg NA; Ely LK; Beddoe T; Macdonald WA; Reid HH; Clements CS; Purcell AW; Kjer-Nielsen L; Miles JJ; Burrows SR; McCluskey J; Rossjohn J
    Nat Immunol; 2005 Feb; 6(2):171-80. PubMed ID: 15640805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T-cell Receptors Engineered
    Sharma P; Harris DT; Stone JD; Kranz DM
    Cancer Immunol Res; 2019 Dec; 7(12):2025-2035. PubMed ID: 31548259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural alterations in peptide-MHC recognition by self-reactive T cell receptors.
    Wucherpfennig KW; Call MJ; Deng L; Mariuzza R
    Curr Opin Immunol; 2009 Dec; 21(6):590-5. PubMed ID: 19699075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Computational design of the affinity and specificity of a therapeutic T cell receptor.
    Pierce BG; Hellman LM; Hossain M; Singh NK; Vander Kooi CW; Weng Z; Baker BM
    PLoS Comput Biol; 2014 Feb; 10(2):e1003478. PubMed ID: 24550723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opposite effects of endogenous peptide-MHC class I on T cell activity in the presence and absence of CD8.
    Stone JD; Aggen DH; Chervin AS; Narayanan S; Schmitt TM; Greenberg PD; Kranz DM
    J Immunol; 2011 May; 186(9):5193-200. PubMed ID: 21451107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting interactions between T cell receptors and MHC-peptide complexes.
    Roomp K; Domingues FS
    Mol Immunol; 2011 Jan; 48(4):553-62. PubMed ID: 21106246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-affinity, peptide-specific T cell receptors can be generated by mutations in CDR1, CDR2 or CDR3.
    Chlewicki LK; Holler PD; Monti BC; Clutter MR; Kranz DM
    J Mol Biol; 2005 Feb; 346(1):223-39. PubMed ID: 15663940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The contribution of major histocompatibility complex contacts to the affinity and kinetics of T cell receptor binding.
    Zhang H; Lim HS; Knapp B; Deane CM; Aleksic M; Dushek O; van der Merwe PA
    Sci Rep; 2016 Oct; 6():35326. PubMed ID: 27734930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.